EurekaMag.com logo
+ Site Statistics
References:
53,869,633
Abstracts:
29,686,251
+ Search Articles
+ Subscribe to Site Feeds
EurekaMag Most Shared ContentMost Shared
EurekaMag PDF Full Text ContentPDF Full Text
+ PDF Full Text
Request PDF Full TextRequest PDF Full Text
+ Follow Us
Follow on FacebookFollow on Facebook
Follow on TwitterFollow on Twitter
Follow on LinkedInFollow on LinkedIn

+ Translate

RAGE: the beneficial and deleterious effects by diverse mechanisms of actions



RAGE: the beneficial and deleterious effects by diverse mechanisms of actions



Molecules and Cells 31(2): 91-97



Receptor for advanced glycation endproducts (RAGE) is a transmembrane protein that belongs to the immunoglobulin superfamily. RAGE is expressed ubiquitously-high in lung and moderate to low in a wide range of cells-in a tightly regulated manner at various stages of development. RAGE is a pattern recognition receptor that binds to multiple ligands, including amphoterin, members of the S100/calgranulin family, the integrin Mac-1, and amyloid β-peptide (Aβ). RAGE-ligand engagement effects the activation of diverse cascades that initiate and stimulate chronic stress pathways and repair, depending on the ligand, environment, and developmental stage. Further, RAGE-ligand interaction and the consequent upregulation of RAGE through a positive feedback loop are often associated with various diseases, including vascular disease, diabetes, cancer, and neurodegenerative disease. It is unknown how RAGE mediates these events, but such phenomena appear to be linked to the inflammatory response. In this review, we summarize the findings on RAGE from published reports and ongoing studies. Also, the implication of RAGE in Alzheimer disease, the most common neurodegenerative disease in the elderly population, will be discussed, with a focus on Aβ-RAGE interactions with regard to signaling pathways and their impact on cellular activity.

(PDF emailed within 0-6 h: $19.90)

Accession: 055333039

Download citation: RISBibTeXText

PMID: 21347704

DOI: 10.1007/s10059-011-0030-x



Related references

Coalescing beneficial host and deleterious antiparasitic actions as an antischistosomal strategy. Elife 7, 2018

Dietary polyphenols as modulators of brain functions: biological actions and molecular mechanisms underpinning their beneficial effects. Oxidative Medicine and Cellular Longevity 2012: 914273-914273, 2012

New concepts in the pathophysiology of heart failure: Beneficial and deleterious interaction of endogenous haemodynamic and neurohormonal mechanisms. Journal of Internal Medicine 239(4): 327-333, 1996

Beneficial and deleterious effects of alcoholic beverages. La Revue du Praticien 49(4): 367-372, 1999

Skeletal site-specific effects of whole body vibration in mature rats: from deleterious to beneficial frequency-dependent effects. Bone 55(1): 69-77, 2013

Beneficial and deleterious effects of physical effort on the heart and vessels. Bruxelles Medical 48(6): 351-356, 1968

Beneficial and deleterious effects of HCN-producing pseudomonads on rhizosphere interactions. Plant and Soil 129(1): 75-83, 1990

Cooling dialysate during in-center hemodialysis: Beneficial and deleterious effects. World Journal of Nephrology 5(2): 166-171, 2016

Beneficial and deleterious effects of hydroxycitrate in rats fed a high-fructose diet. Nutrition 22(9): 905-912, 2006

Metabolism of plant polyphenols in the skin: beneficial versus deleterious effects. Current Drug Metabolism 9(8): 710-729, 2008

Antioxidants and muscle atrophy in colon cancer: beneficial or deleterious effects?. Free Radical Biology & Medicine 75 Suppl 1: S22-S22, 2015

Dominance effects of deleterious and beneficial mutations in a single gene of the RNA virus ϕ6. Plos One 9(6): E97717-E97717, 2015

Beneficial effects of a novel RAGE inhibitor on early diabetic retinopathy and tactile allodynia. Molecular Vision 17(): 3156-3165, 2012

Prostaglandin E2: molecular mechanisms for its diverse actions. Seikagaku. Journal of Japanese Biochemical Society 66(3): 218-231, 1994

Beneficial and deleterious effects of rosiglitazone on hypertension development in spontaneously hypertensive rats. American Journal of Hypertension 17(9): 749-756, 2004